Jingjia Cao
7PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Feb 02, 2026
The peripheral blood lymphocyte signatures forecast therapeutic efficacy in papillary thyroid cancer patients undergoing radioactive iodine therapy.Jingjia Cao, Yaru Sun, Zihui Xu
|Feb 20, 2025
The efficacy analysis of radioactive iodine therapy for familial non-medullary thyroid cancer in the era of personalized medicine: a cohort study and a meta-analysis.Jingjia Cao, Xiang Li, Huazhen Liang
|Jul 26, 2024
The impact of Hashimoto's thyroiditis on the clinical outcome of papillary thyroid cancer after radioactive iodine therapy: a propensity score matching study.Jingjia Cao, Yaru Sun, Yang Liu
|Oct 18, 2023
BRAF V600E mutation in papillary thyroid microcarcinoma: is it a predictor for the prognosis of patients with intermediate to high recurrence risk?Jingjia Cao, Baojin Chen, Xiaolu Zhu
|May 02, 2022
The genetic duet of BRAF V600E and TERT promoter mutations predicts the poor curative effect of radioiodine therapy in papillary thyroid cancer.Jingjia Cao, Xiaolu Zhu, Yaru Sun
|Jun 24, 2021
Clinical Analysis of the Short-Term Outcome of Papillary Thyroid Micro Carcinoma After 131I Treatment.Jingjia Cao, Canhua Yun, Xiaolu Zhu
Pageof 2
